Status:
RECRUITING
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
Lead Sponsor:
All Natural Medicine Clinic, LLC
Conditions:
Covid19 Virus Infection
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
The human immune system is designed to protect individuals from external sources of infection and internal cell mutation. It works effectively and efficiently until inflammation disturbs its functioni...
Detailed Description
According to CDC data, as of January 30, 2021, 25,780,144 individuals residing in the United States had been infected by COVID-19 and 435,151 had died as a result of the disease. No drug has yet been ...
Eligibility Criteria
Inclusion
- A subject will be eligible for inclusion in this study if any of the following criteria apply:
- Individuals diagnosed with COVID-19 virus infection in the past 1-20 days must submit the proved metrics of COVID-19 virus marks positive during the registration;
- The age of participants is between 10-70 years old;
- The participants are received or not received conventional medication treatment, and continuing the treatment patients, could be enrolled in this clinical study;
- This clinical study is not restricted to gender, age, sex, race, and nationality;
- The participants must have reports of CBC, C3, C4, IgM, IgG, CD4/CD8, and lungs' images ready before the clinical study;
- The Participants must repeat the evaluation experiment during and at the end of the clinical study.
Exclusion
- A subject will not be eligible for inclusion in this study if any of the following criteria apply:
- Individuals with a prior COVID-19 virus infection that no longer shows up from COVID-19 testing;
- Children who are younger than 10-year-old, cannot control themselves to take the medical herbs on time;
- Elders whose age beyond 70-year-old, with severe underline illness;
- COVID-19 virus-infected patients who do not feel willing to take medical herbs;
- Patients diagnosed with COVID-19 virus infection cannot consistently finish the treatment courses for a specific reason;
- Patients diagnosed with COVID-19 virus infection but do not willing to share their information with the public;
- Current or past participation within a specified timeframe in another clinical trial, as warranted by this intervention's administration;
- Severe patients, when there have insufficient normal cells, can be adjusted, with pre-list diseases life-threatening.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04790240
Start Date
January 1 2025
End Date
May 30 2027
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All Natural Medicine Clinic, LLC
Rockville, Maryland, United States, 20852-2235